195 related articles for article (PubMed ID: 18347106)
1. Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.
Bellecave P; Cazenave C; Rumi J; Staedel C; Cosnefroy O; Andreola ML; Ventura M; Tarrago-Litvak L; Astier-Gin T
Antimicrob Agents Chemother; 2008 Jun; 52(6):2097-110. PubMed ID: 18347106
[TBL] [Abstract][Full Text] [Related]
2. Selection of DNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus and inhibit viral RNA synthesis in vitro.
Bellecave P; Andreola ML; Ventura M; Tarrago-Litvak L; Litvak S; Astier-Gin T
Oligonucleotides; 2003; 13(6):455-63. PubMed ID: 15025912
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
Lee CH; Lee YJ; Kim JH; Lim JH; Kim JH; Han W; Lee SH; Noh GJ; Lee SW
J Virol; 2013 Jun; 87(12):7064-74. PubMed ID: 23596299
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of hepatitis C virus production by aptamers against the core protein.
Shi S; Yu X; Gao Y; Xue B; Wu X; Wang X; Yang D; Zhu H
J Virol; 2014 Feb; 88(4):1990-9. PubMed ID: 24307579
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of hepatitis C virus infection by NS5A-specific aptamer.
Yu X; Gao Y; Xue B; Wang X; Yang D; Qin Y; Yu R; Liu N; Xu L; Fang X; Zhu H
Antiviral Res; 2014 Jun; 106():116-24. PubMed ID: 24713119
[TBL] [Abstract][Full Text] [Related]
6. Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
Schult P; Nattermann M; Lauber C; Seitz S; Lohmann V
J Virol; 2019 Oct; 93(19):. PubMed ID: 31315989
[TBL] [Abstract][Full Text] [Related]
7. High-affinity aptamers to subtype 3a hepatitis C virus polymerase display genotypic specificity.
Jones LA; Clancy LE; Rawlinson WD; White PA
Antimicrob Agents Chemother; 2006 Sep; 50(9):3019-27. PubMed ID: 16940097
[TBL] [Abstract][Full Text] [Related]
8. CS-SELEX generates high-affinity ssDNA aptamers as molecular probes for hepatitis C virus envelope glycoprotein E2.
Chen F; Hu Y; Li D; Chen H; Zhang XL
PLoS One; 2009 Dec; 4(12):e8142. PubMed ID: 19997645
[TBL] [Abstract][Full Text] [Related]
9. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein.
Gao Y; Yu X; Xue B; Zhou F; Wang X; Yang D; Liu N; Xu L; Fang X; Zhu H
PLoS One; 2014; 9(2):e90333. PubMed ID: 24587329
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of hepatitis C virus infection by DNA aptamer against envelope protein.
Yang D; Meng X; Yu Q; Xu L; Long Y; Liu B; Fang X; Zhu H
Antimicrob Agents Chemother; 2013 Oct; 57(10):4937-44. PubMed ID: 23877701
[TBL] [Abstract][Full Text] [Related]
12. A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A.
Ranjith-Kumar CT; Wen Y; Baxter N; Bhardwaj K; Cheng Kao C
PLoS One; 2011; 6(7):e22575. PubMed ID: 21799903
[TBL] [Abstract][Full Text] [Related]
13. Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.
Aligeti M; Roder A; Horner SM
J Virol; 2015 Nov; 89(22):11523-33. PubMed ID: 26355084
[TBL] [Abstract][Full Text] [Related]
14. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.
McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G
Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234
[TBL] [Abstract][Full Text] [Related]
15. Selection of RNA aptamers that are specific and high-affinity ligands of the hepatitis C virus RNA-dependent RNA polymerase.
Biroccio A; Hamm J; Incitti I; De Francesco R; Tomei L
J Virol; 2002 Apr; 76(8):3688-96. PubMed ID: 11907208
[TBL] [Abstract][Full Text] [Related]
16. Enzymatic characterization of the full-length and C-terminally truncated hepatitis C virus RNA polymerases: function of the last 21 amino acids of the C terminus in template binding and RNA synthesis.
Vo NV; Tuler JR; Lai MM
Biochemistry; 2004 Aug; 43(32):10579-91. PubMed ID: 15301555
[TBL] [Abstract][Full Text] [Related]
17. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture.
Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I
J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989
[TBL] [Abstract][Full Text] [Related]
18. RNA aptamer-mediated interference of HCV replication by targeting the CRE-5BSL3.2 domain.
Marton S; Romero-López C; Berzal-Herranz A
J Viral Hepat; 2013 Feb; 20(2):103-12. PubMed ID: 23301545
[TBL] [Abstract][Full Text] [Related]
19. In vitro selection of RNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus: a possible role of GC-rich RNA motifs in NS5B binding.
Kanamori H; Yuhashi K; Uchiyama Y; Kodama T; Ohnishi S
Virology; 2009 May; 388(1):91-102. PubMed ID: 19328515
[TBL] [Abstract][Full Text] [Related]
20. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
Ahmed-Belkacem A; Ahnou N; Barbotte L; Wychowski C; Pallier C; Brillet R; Pohl RT; Pawlotsky JM
Gastroenterology; 2010 Mar; 138(3):1112-22. PubMed ID: 19962982
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
